Literature DB >> 8912788

Identification of an E689K substitution as the molecular basis of the human acid alpha-glucosidase type 4 allozyme (GAA*4).

M L Huie1, M Menaker, P J McAlpine, R Hirschhorn.   

Abstract

We have identified the molecular basis of the GAA*4 allozyme as a G to A transition at nt2065 which predicts the substitution of glutamic acid by lysine at codon 689 (E689K). The conclusion that this change represents the molecular basis of the GAA*4 allozyme is based on 1) presence of the G2065A in homozygosity in a known GAA*4 homozygote, 2) transient expression studies showing normal enzyme activity expressed by cDNA containing the G2065A transition and 3) isoelectric focusing studies showing a more cathodal pattern for the expressed product as compared to the common GAA*1, analogous to the patterns seen in normal and known GAA*4 lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912788     DOI: 10.1111/j.1469-1809.1996.tb00433.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  5 in total

Review 1.  Molecular genetics of Pompe disease: a comprehensive overview.

Authors:  Paolo Peruzzo; Eleonora Pavan; Andrea Dardis
Journal:  Ann Transl Med       Date:  2019-07

2.  Duchenne Muscular Dystrophy With Low Acidic α-Glucosidase Activity: Two Case Reports and Literature Review.

Authors:  Xiufang He; Xuandi Li; Yuese Lin; Hongjun Ba; Huimin Peng; Lili Zhang; Ling Zhu; Youzhen Qin; Shujuan Li
Journal:  Front Pediatr       Date:  2022-06-01       Impact factor: 3.569

3.  Structural and biochemical studies on Pompe disease and a "pseudodeficiency of acid alpha-glucosidase".

Authors:  Youichi Tajima; Fumiko Matsuzawa; Sei-Ichi Aikawa; Toshika Okumiya; Michiru Yoshimizu; Takahiro Tsukimura; Masahiko Ikekita; Seiichi Tsujino; Akihiko Tsuji; Tim Edmunds; Hitoshi Sakuraba
Journal:  J Hum Genet       Date:  2007-09-06       Impact factor: 3.172

4.  Classic infantile-onset Pompe disease with histopathological neurologic findings linked to a novel GAA gene 4 bp deletion: A case study.

Authors:  Magdalena Cerón-Rodríguez; Daniela Castillo-García; Carlos-Patricio Acosta-Rodríguez-Bueno; Jesús Aguirre-Hernández; Juan-Rafael Murillo-Eliosa; Pedro Valencia-Mayoral; Argelia Escobar-Sánchez; Juan-Luis Salgado-Loza
Journal:  Mol Genet Genomic Med       Date:  2022-05-09       Impact factor: 2.473

5.  Clinical and molecular characterization of Korean children with infantile and late-onset Pompe disease: 10 years of experience with enzyme replacement therapy at a single center.

Authors:  Min-Sun Kim; Ari Song; Minji Im; June Huh; I-Seok Kang; Jinyoung Song; Aram Yang; Jinsup Kim; Eun-Kyung Kwon; Eu-Jin Choi; Sun-Ju Han; Hyung-Doo Park; Sung Yoon Cho; Dong-Kyu Jin
Journal:  Korean J Pediatr       Date:  2018-10-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.